microRNA Biomarkers as Potential Diagnostic Markers for Cancer - Genomic Biomarkers for Pharmaceutical Development - page 118

[85] Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, et al. MicroRNA expression alterations
are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene
2007;26:4442-52.
[86] Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to dif-
ferentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297:1901-8.
[87] Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, et al. Proiling of 95 microRNAs in pancreatic cancer cell
lines and surgical specimens by real-time PCR analysis. World J Surg 2009;33:698-709.
[88] Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and
a potential predictor of survival. J Gastrointest Surg 2008;12:2171-6.
[89] Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, et al. Expression proiling identiies microRNA
signature in pancreatic cancer. Int J Cancer 2007;120:1046-54.
[90] Munding JB, Adai AT, Maghnouj A, Urbanik A, Zollner H, Liffers ST, et al. Global microRNA expression pro-
iling of microdissected tissues identiies miR-135b as a novel biomarker for pancreatic ductal adenocarci-
noma. Int J Cancer 2012;131(2):E86-95.
[91] Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H. Elevated expression of microRNAs
155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010;126:73-80.
[92] Szafranska AE, Doleshal M, Edmunds HS, Gordon S, Luttges J, Munding JB, et al. Analysis of microRNAs in
pancreatic ine-needle aspirates can classify benign and malignant tissues. Clin Chem 2008;54:1716-24.
[93] Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias.
Clin Cancer Res 2012;18:981-92.
[94] Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, et al. The silencing of microRNA
148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem
2010;56:1107-18.
[95] Matthaei H, Maitra A. Precursor lesions of pancreatic cancer, Fitzgerald RC, editor. Pre-invasive disease:
pathogenesis and clinical management. New York: Springer; 2011, pp. 395-420.
[96] Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, et al. Prevalence of unsuspected
pancreatic cysts on MDCT. Am J Roentgenol 2008;191:802-7.
[97] Visser BC, Yeh BM, Qayyum A, Way LW, McCulloch CE, Coakley FV. Characterization of cystic pancreatic
masses: relative accuracy of CT and MRI. AJR Am J Roentgenol 2007;189:648-56.
[98] Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pan-
creatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330-6.
[99] Gerke H, Jaffe TA, Mitchell RM, Byrne MF, Stifler HL, Branch MS, et al. Endoscopic ultrasound and
computer tomography are inaccurate methods of classifying cystic pancreatic lesions. Dig Liver Dis
2006;38:39-44.
[100] Ahmad NA, Kochman ML, Brensinger C, Brugge WR, Faigel DO, Gress FG, et al. Interobserver agreement
among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions.
Gastrointest Endosc 2003;58:59-64.
[101] Lai R, Stanley MW, Bardales R, Linzie B, Mallery S. Endoscopic ultrasound-guided pancreatic duct aspira-
tion: diagnostic yield and safety. Endoscopy 2002;34:715-20.
[102] Maire F, Couvelard A, Hammel P, Ponsot P, Palazzo L, Aubert A, et al. Intraductal papillary mucinous tumors
of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc
2003;58:701-6.
[103] Frossard JL, Amouyal P, Amouyal G, Palazzo L, Amaris J, Soldan M, et al. Performance of endosonography-
guided ine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol
2003;98:1516-24.
[104] van der Waaij LA, van Dullemen HM, Porte RJ. Cyst luid analysis in the differential diagnosis of pancreatic
cystic lesions: a pooled analysis. Gastrointest Endosc 2005;62:383-9.
[105] Kucera S, Centeno BA, Springett G, Malafa MP, Chen YA, Weber J, et al. Cyst luid carcinoembryonic antigen
level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the
pancreas. JOP 2012;13:409-13.
[106] Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, et al. Pancreatic cyst luid DNA analy-
sis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009;69:1095-102.
[107] Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, et al. Recurrent GNAS mutations deine
an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011;3:92ra66.